Cargando…

Circulating cytokeratin-positive cells and tumor budding in colorectal cancer

AIM: To investigate whether circulating cytokeratin-positive (CK(+)) cells in the mesenteric blood of resected colorectal specimens are prognostic and correlate with tumor budding. METHODS: Fifty-six colorectal specimens were collected between 9/2007 and 7/2008. Blood from the mesenteric vein was dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Märkl, Bruno, Wilhelms, Narjes, Anthuber, Matthias, Schenkirsch, Gerhard, Schlimok, Günter, Oruzio, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143437/
https://www.ncbi.nlm.nih.gov/pubmed/28008384
http://dx.doi.org/10.5306/wjco.v7.i6.433
_version_ 1782472940224249856
author Märkl, Bruno
Wilhelms, Narjes
Anthuber, Matthias
Schenkirsch, Gerhard
Schlimok, Günter
Oruzio, Daniel
author_facet Märkl, Bruno
Wilhelms, Narjes
Anthuber, Matthias
Schenkirsch, Gerhard
Schlimok, Günter
Oruzio, Daniel
author_sort Märkl, Bruno
collection PubMed
description AIM: To investigate whether circulating cytokeratin-positive (CK(+)) cells in the mesenteric blood of resected colorectal specimens are prognostic and correlate with tumor budding. METHODS: Fifty-six colorectal specimens were collected between 9/2007 and 7/2008. Blood from the mesenteric vein was drawn immediately after receiving the fresh and unfixed specimens in the pathology department. After separation of the mononuclear cells by Ficoll-Hypaque density-gradient centrifugation, cytological smears were immunocytochemically stained for CK18. Tumor budding was evaluated on slides stained for pan-cytokeratin. The identification of ≥ 30 buds/1.3 mm(2) was defined as high grade budding. RESULTS: CK(+) cells and clusters were identified in 29 (48%) and 14 (25%) of the samples, respectively. Two cells were identified in one of three non-malignant cases. Clusters were found exclusively in malignant cases. The occurrence of CK(+) cells or clusters was not associated with any of the evaluated clinicopathological factors, including surgical technique and tumor budding. Moreover, the occurrence of CK(+) cells or clusters had no influence on the cancer-specific survival [75 mo (CI: 61; 88) vs 83 mo (CI: 72; 95) and 80 mo (CI: 63; 98) vs 79 mo (CI: 69; 89), respectively]. CONCLUSION: CK(+) cells and showed neither prognostic significance nor an association with tumor budding. It is very likely that CK18-staining is not specific enough to identify the relevant cells.
format Online
Article
Text
id pubmed-5143437
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-51434372016-12-23 Circulating cytokeratin-positive cells and tumor budding in colorectal cancer Märkl, Bruno Wilhelms, Narjes Anthuber, Matthias Schenkirsch, Gerhard Schlimok, Günter Oruzio, Daniel World J Clin Oncol Retrospective Study AIM: To investigate whether circulating cytokeratin-positive (CK(+)) cells in the mesenteric blood of resected colorectal specimens are prognostic and correlate with tumor budding. METHODS: Fifty-six colorectal specimens were collected between 9/2007 and 7/2008. Blood from the mesenteric vein was drawn immediately after receiving the fresh and unfixed specimens in the pathology department. After separation of the mononuclear cells by Ficoll-Hypaque density-gradient centrifugation, cytological smears were immunocytochemically stained for CK18. Tumor budding was evaluated on slides stained for pan-cytokeratin. The identification of ≥ 30 buds/1.3 mm(2) was defined as high grade budding. RESULTS: CK(+) cells and clusters were identified in 29 (48%) and 14 (25%) of the samples, respectively. Two cells were identified in one of three non-malignant cases. Clusters were found exclusively in malignant cases. The occurrence of CK(+) cells or clusters was not associated with any of the evaluated clinicopathological factors, including surgical technique and tumor budding. Moreover, the occurrence of CK(+) cells or clusters had no influence on the cancer-specific survival [75 mo (CI: 61; 88) vs 83 mo (CI: 72; 95) and 80 mo (CI: 63; 98) vs 79 mo (CI: 69; 89), respectively]. CONCLUSION: CK(+) cells and showed neither prognostic significance nor an association with tumor budding. It is very likely that CK18-staining is not specific enough to identify the relevant cells. Baishideng Publishing Group Inc 2016-12-10 2016-12-10 /pmc/articles/PMC5143437/ /pubmed/28008384 http://dx.doi.org/10.5306/wjco.v7.i6.433 Text en ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Study
Märkl, Bruno
Wilhelms, Narjes
Anthuber, Matthias
Schenkirsch, Gerhard
Schlimok, Günter
Oruzio, Daniel
Circulating cytokeratin-positive cells and tumor budding in colorectal cancer
title Circulating cytokeratin-positive cells and tumor budding in colorectal cancer
title_full Circulating cytokeratin-positive cells and tumor budding in colorectal cancer
title_fullStr Circulating cytokeratin-positive cells and tumor budding in colorectal cancer
title_full_unstemmed Circulating cytokeratin-positive cells and tumor budding in colorectal cancer
title_short Circulating cytokeratin-positive cells and tumor budding in colorectal cancer
title_sort circulating cytokeratin-positive cells and tumor budding in colorectal cancer
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143437/
https://www.ncbi.nlm.nih.gov/pubmed/28008384
http://dx.doi.org/10.5306/wjco.v7.i6.433
work_keys_str_mv AT marklbruno circulatingcytokeratinpositivecellsandtumorbuddingincolorectalcancer
AT wilhelmsnarjes circulatingcytokeratinpositivecellsandtumorbuddingincolorectalcancer
AT anthubermatthias circulatingcytokeratinpositivecellsandtumorbuddingincolorectalcancer
AT schenkirschgerhard circulatingcytokeratinpositivecellsandtumorbuddingincolorectalcancer
AT schlimokgunter circulatingcytokeratinpositivecellsandtumorbuddingincolorectalcancer
AT oruziodaniel circulatingcytokeratinpositivecellsandtumorbuddingincolorectalcancer